ETR vs NRIX · P/E 28, rev $12.95B vs rev $54.5M
Entergy Corporation (ETR) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the ETR and NRIX stock pages for the full models.
Not investment advice.